Background: Burkholderia ambifaria is a plant associated bacteria responsible for opportunistic infections in human. Result: The -propeller BambL lectin is specific for fucosylated oligosaccharides with higher affinity for biological samples from secretors individuals.
SUMMARY
Burkholderia ambifaria is generally associated with the rhizosphere of plants where it has biocontrol effects on other microorganisms. It is also a member of the Burkhoderia cepacia complex, a group of closely related bacteria that causes lung infections in immunocompromised patients, as well as patients with granulomatous disease or cystic fibrosis. Our The Burkholderia cepacia complex (Bcc) is a group of genetically distinct but phenotypically similar gram-negative bacteria that are divided into at least seventeen species (1, 2) . Bcc species have interesting antifungal properties that give them environmental and biotechnological potential (3) . Usually non pathogenic for healthy individuals, Bcc can cause a variety of infections in immunocompromised patients, as well as in patients with cystic fibrosis (CF) and granulomatous disease (CGD). It is responsible for the "cepacia syndrome" that leads to rapid lung deterioration and death in most cases (4, 5) . A number of virulence factors have been described and characterized in Bcc isolates, including pili, flagella, type III secretion system, surface exopolysaccharides, proteases and other secreted enzymes as well as ability to form biofilms (6) . Unfortunately, most of the Bcc organisms are highly resistant to all major classes of antibiotics (7) which makes the treatment of patients infected with Bcc problematic.
Genomovar VII of Bcc, also called B. ambifaria, is an example of an organism with dual action since it is able to protect plants against fungal infection, but also to cause infections in human (4, 8) . B. ambifaria is a major component of the rhizosphere of many crop plants, including maize (9) . It has been commercially used as a biopesticide for a few years (10) . At the same time, this species is also an opportunistic human pathogen, particularly problematic in CF patients (8) . No clear distinction can be established between environmental and pathogenic B. ambifaria isolates, and the adaptation to different environment seems to be related to phase variation (11) .
Opportunistic bacteria often use lectins, i.e. protein receptors with high specificity for glycoconjugates, to recognize and adhere to human tissues (12, 13) . More particularly, fucosylated glycoconjugates are present in higher quantity in CF lungs (14) and appear to be a target for lectins from pathogenic bacteria such as Pseudomonas aeruginosa (15) and Burkholderia cenocepacia (16, 17) . Fucosylated glycans are also present in plant cell walls and can act as targets for bacterial receptors (18) . Analysis of the available genomes of B. ambifaria allowed us to identify a new fucosebinding lectin, BambL, with no similarities to lectins from P. aeruginosa and B. cenocepacia but related to lectins from the fungus Aleuria aurantia and from phytopathogenic bacterium Ralstonia solanacearum (18) . The present paper describes the cloning, production and binding properties of recombinant BambL. Based on its specificity determined by screening of a glycan microarray, a large panel of fucosylated oligosaccharides (Table 1) was screened by glycan array and SPR and rationalized through the crystal structures of several complexes. The very strong affinity for human epitopes H-type 2 and Lewis Y and for plant cell wall fucosylated xyloglucans was confirmed by titration microcalorimetry. Binding to membraneembedded glycosphingolipids was tested on a giant unilamellar vesicle model. Possible involvement in binding to human tissue was evaluated by binding to saliva and airway epithelia from humans with different blood group phenotypes.
MATERIAL AND METHODS
Material ─ α-Methyl-fucoside was purchased from Sigma-Aldrich, and disaccharides (Fucα1-2Gal, Fucα1-6GlcNAc, lactose) and fucosyllactose (Fucα1-2Galβ1-4Glc) from Dextra (Reading, UK). All other human histoblood group oligosaccharides and xyloglucan were purchased from Elicityl (Crolles, France).
Production of recombinant bacterial lectins ─ A nucleotide sequence coding for the peptide sequence of BambL from B. ambifaria AMMD (Genbank: YP_777296 or Uniprot: Q0B4G1_BURCM) was synthesized after codon optimization for expression in Escherichia coli (GenScript, Piscataway, USA). It was introduced into the expression vector pET25b using NdeI and BamHI restriction sites. The pET25-BambL vector was transformed into E. coli BL21(DE3) (Novagen) and cells harboring pET25-BambL plasmid were grown in LB broth containing 100 µg ml -1 ampicillin at 37°C until OD 600 reaches 0.7. The cells were then cultured for 16h after addition of 0.5mM isopropyl-β-Dthiogalactopyranoside. After centrifugation (7000 g, 15 min), bacteria were resuspended in equilibration buffer (20mM Tris/HCl pH 7.5, 150 mM NaCl) and broken by cell disruption at a pressure of 1.7 kBar (Constant Cell Disruption System). After centrifugation (50000 g, 30 min, 4°C) and filtration, affinity chromatography on a mannose-agarose column (Sigma-Aldrich) was performed on the supernatant. BambL was allowed to bind to immobilized mannose in equilibration buffer and after washing (20 mM Tris/HCl pH 7.5, 1 M NaCl); it was eluted with 100 mM Mannose in equilibration buffer. Purified protein was extensively dialysed against ultrapure water for 7 days, freeze dried and stored at 4°C.
Recombinant RSL was produced as described earlier (18) .
Glycan Array ─ Purified BambL and RSL samples were labeled with Alexa Fluor 488 (Invitrogen, CA) according to manufacturer's instructions and re-purified on a D-Salt polyacrylamide desalting column (Pierce, Rockford IL). Alexa-labeled proteins were used for glycan-array screening with standard procedure of the Protein-glycan Interaction Core (H) of the Consortium for Functional Glycomics (CFG) (http://www.functional glycomics.org).
In order to determine the fine specificity of BambL, its binding to glycans on version 4.1 of the CFG glycan array comprised of 465 natural and synthetic glycans was analyzed in a dosedependent manner as previously described (19) at 1, 0.2 and 0.05 µg ml -1 of lectin, dissolved in 20 mM HEPES, 140 mM NaCl, 5 mM CaCl 2 , pH 7.5. Briefly, the binding of BambL at different concentrations to each glycan was normalized to percentages of the highest RFU value for each analysis, and the % of maximum binding for each glycan at the different lectin concentrations was averaged to obtain an average ranking.
The data were sorted according to the average ranking to obtain the order of relative binding of the glycans on the array.
Microcalorimetry ─ Recombinant lyophilized BambL was dissolved in buffer (20 mM Tris/HCl pH 7.5, NaCl 150 mM) and degassed. Protein concentration was checked by measurement of A 280 by using a theoretical molar extinction coefficient of 40,450 M -1 cm -1 . Carbohydrate ligands were dissolved in the same buffer, degassed and loaded in the injection syringe. ITC was performed with a VP-ITC microcalorimeter (MicroCal Inc.). BambL solution was placed in the 1.4478 ml sample cell, at 25°C. Titration was performed with 10 µl injections of carbohydrate ligands every 300 s. Data were fitted with MicroCal Origin 7 software, according to standard procedures. Fitted data yielded the stoichiometry (n), the association contant (K a ) and the enthalpy of binding (ΔH). Other thermodynamic parameters (i.e. changes in free energy, ΔG, and entropy, ΔS) were calculated from the equation ΔG=ΔH-TΔS=RTlnK a in which T is the absolute temperature and R=8.314 J mol -1 K -1 . Two independent titrations were performed for each ligand tested.
Surface Plasmon Resonance ─ SPR inhibition experiments were performed on a Biacore X100 instrument (GE Healthcare) at 25°C in HBS buffer (10 mM Hepes/NaOH pH 7.5, 150 mM NaCl, 0.05 % Tween 20) and at a flow rate of 10 µl min -1 . Streptavidin was immobilized on a research grade CM5 chip using standard procedures and 300 resonance units (RU) of biotinylated polyacrylamide probes (Lectinity, 200 µg ml -1 ) bearing galactose or fucose were captured on channel 1 (reference) and 2 respectively. Inhibition experiments were performed with the fucosylated channel 2 and plots represent substracted data (Channel 2 -Channel 1). Inhibition studies consisted of the injection (association 240 s, dissociation 600 s) of incubated (>30 min, RT) mixtures of BambL (1 µM) and various concentrations of inhibitor (3-fold cascade dilutions). For each inhibition assay, BambL was injected to observe the full adhesion of the lectin onto the sugar-coated surface (0% inhibition). The chip was fully regenerated by 2 successive injections of Lfucose (120 s, 1 M in running buffer).
Binding was measured as RU over time after blank subtraction, and data were then evaluated by using the Biacore X100 Evaluation Software version 2.0. For IC50 evaluation, the response (Req) was considered as the amount of lectin bound to the sugar surface at equilibrium in the presence of a defined concentration of inhibitor. Inhibition curves were obtained by plotting the percentage of inhibition against the inhibitor concentration (logarithmic scale).
Protein crystallography ─ Crystals of BambL complexed with fucosylated oligosaccharides were obtained by the hanging-drop vapour diffusion method using 2 μl drops containing a 50:50 (v/v) mix of protein and reservoir solution at 20 °C. Lyophilized protein was dissolved in Tris/HCl buffer pH 7.5, NaCl 150 mM at 1 mM and incubated for 1 h with H-type 5 (FucLac), H-type 1, H-type 2 and B-penta oligosaccharides (5 mM) at room temperature prior to cocrystallization. Crystals of the different complex were obtained from 200 mM trisodium citrate, 100 mM sodium acetate pH 5.0 and 24 % PEG 8K for the complex with FucLac, 3 M malonate pH 6.0 for H-type 1 and H-type 2 complexes and 1M lithium chloride, 100 mM bicine pH 9.0 and 30% PEG 6K for B-tetra complex. For all crystals except the one with B-tetra, 10% ethyleneglycol was added to the mother liquor prior mounting in a cryoloop and freezing in liquid nitrogen. Diffraction data were collected at 100K, at the European Synchrotron Radiation Facility (Grenoble, France) at station ID14-EH4 or BM30A using an ADSC Q4 CCD detector. The data were processed using MOSFLM (20) and scaled and converted to structure factors using SCALA. All further computing was performed using the CCP4 suite (21) unless otherwise stated. Data quality statistics are summarised in Table 2 .
Molecular replacement technique was used to solve the different structures with PHASER (22) and the coordinates of the RSL (PDB code 2BT9) as search model (18) for the FucLac complex structure. For the other liganded structures, coordinates of the lastest (PDB code 3zw0) were used as search model. Five percent of the observations were set aside for crossvalidation analysis (23) , and hydrogen atoms were added in their riding positions and used for geometry and structure-factor calculations. The structure was refined by restrained maximumlikelihood refinement using REFMAC (24), iterated with manual rebuilding in Coot (25) . In each complex, the incorporation of the ligands was performed after inspection of the mFo −DFc weighted maps, and the initial maps revealed clear density for the fucose moiety, and the number of additional sugars that could be observed depended on the sites and ligand. Water molecules were introduced automatically using Coot and inspected manually. The stereochemical quality of the models was assessed with the program Procheck (26), and coordinates have been deposited in the Protein Data Bank under code 3zw1 (H-type1), 3zwe (B-tetra) and 3zzv (H-type2). Molecular drawings were prepared using PyMOL Molecular Graphics System (DeLano Scientific, Palo Alto, CA) and LIGPLOT (http://www.ebi.ac.uk/thorntonsrv/software/LIGPLOT/) (27) .
Production of giant unilamellar vesicles by electroformation and lectin binding to glycosphingolipid-containing liposomes ─ The lipids
1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC) and cholesterol (chol) were purchased from Avanti Polar Lipids (Alabaster), Bodipy-FL-C5 hexadecanoyl phosphatidylcholine (HPC) was from Molecular Probes (Invitrogen) and globotriaosylceramide (Gb3) from Matreya (LLC). The fucosylated type 1 chain glycosphingolipids and the precursor lactotetraosylceramide were isolated from meconia, pooled according to blood group ABO and characterized in detail as described before for a human O Le(a-b+) secretor (28) .
Giant unilamellar vesicles (GUVs) were composed of DOPC (spiked with 1 mol% BodipyFL-C5-HPC, green), cholesterol (30 mol%) and various glycosphingolipid species (5 mol%). GUVs were grown at room temperature using the electroformation technique on ITO slides, essentially as previously described (29, 30) . Briefly, lipid mixtures were dissolved in chloroform at a final concentration of 0.5 mg mL -1 , and 15 μl of solution was spread on conductive faces of ITO slides. After at least 2 hours of drying under vacuum, GUVs are grown in a 290 mOsm sucrose solution by applying an alternating electric field from 20 mV to 1.1 V for 3 hours.
In all conditions, BambL (10 µg mL -1 ) was incubated with GUVs at room temperature and examined under inverted confocal fluorescence microscopes (LSM 510, Carl Zeiss, and A1R, NIKON) equipped with oil immersion objectives.
Binding to human saliva and tissues ─ Saliva samples collected from 59 healthy individuals of known ABO, Secretor and Lewis phenotypes, with confirmed FUT2 (Secretor) and FUT3 (Lewis) genotypes (31, 32) were selected to cover the ABO, Secretor and Lewis phenotypic diversity. The study was approved by the Nantes University Hospital Review Board (study no. BRD02/2-P), and informed consent was obtained from all saliva donors. After collection, samples were boiled for 10 minutes and centrifuged for 5 minutes at 13000 g. To assay BambL binding to saliva, Maxisorb plates (ThermoFischer scientific, Waltham, MA) were coated in duplicates with saliva samples diluted 1/1000 in 100 mM carbonate buffer, pH 9.6. After blocking with 5% defatted dried cow's milk in PBS for 1 hour, biotinylated BambL at 0.1 µg mL -1 , or biotinylated UEA-I (SigmaAldrich, St. Louis, MO) used as a control, at 1 µg mL -1 in PBS 5% defatted dried cow's milk, were added. After incubation for 2 hours at 37°C, HRP conjugated avidin (Vector laboratories, Burlingame, CA) diluted 1/3000 in PBS 5% defatted dried cow's milk was added and incubated for 1 hour at 37C°. Between each step, plates were washed 3 times with PBS 5% Tween 20. The enzyme signals were detected using TMB (3, 3', 5, 5' tetramethylbenzidine) as substrate (BD Bioscience, San Jose, CA) and then read at 450 nm. Inhibition by free sugars was performed by preincubating BamL at 1 mg/mL with either 100 mM fucose or 5 mM 2'fucosyllactose (Fuc2Gal4Glc) for 2 h at room temperature prior to incubation on saliva samples as above.
Human trachea, lung and gastroduodenal junction samples, obtained from organ donors before the law 88-1138 of December 20, 1988 concerning resection of human tissues after death for scientific investigations, were used to prepare tissue micro-arrays. Tissues from 18 individuals were used: O Secretor Lewis + (n=8), A Secretor Lewis + (n=3), B Secretor Lewis + (n=2), O Secretor Lewis -(n=1), O nonsecretor Lewis + (n=4). Sections were deparafinated through baths in LMR and ethanol. Endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide. Non-specific binding was blocked with 1% BSA in PBS for 30 min. After washing with PBS, biotinylated BambL diluted at 0.1 µg mL -1 in 0.1% BSA/PBS was incubated overnight at 4°C. Following 3 washes with PBS, HRP-conjugated avidin (Vector laboratories) diluted 1/2000 in 0.1% BSA/PBS was added and incubated for 45 min at room temperature. After 3 more washings with PBS, substrate was added to the slides (AEC kit, Bector Laboratories, Burlingame, CA) followed by Mayer's hemalum solution (Merck, Whitehouse Station, NJ) for contrast staining.
RESULTS

Production and characterisation of BambL ─
BambL gene has been identified by sequence homology (76.5% protein sequence identity) with Ralstonia solanacearum Lectin (RSL) (18) in chromosome 2 of Burkholderia ambifaria AMMD genome. Except for those two species, this gene has not been identified in other bacterial genomes. BambL has been produced recombinantly in E. coli and purified in one step on a mannose-agarose column with a final yield of 5 mg L -1 of culture. The strong hemagglutination activity (HU=0.4µM) can be inhibited by L-fucose (data not shown) suggesting that BambL is a fucose binding lectin.
Carbohydrate specificity of BambL ─ In order to determine its detailed specificity, BambL binding to the glycans on version 4.1 of the CFG glycan microarray were ranked according to their relative binding as shown in Table S1 (Suppl. Inf.) Of the 465 glycans on v4.1 of the array, 129 contained fucose, and all 68 glycan structures with average rankings >5% possessed a non-reducing terminal fucose residue. A more detailed analysis was performed by focusing only on the 129 fucosylated oligosaccharide ( Figure 1 and Table S2 in Suppl. Inf.). BambL displays a preference on the glycan array for short glycans such as Fuc (#1) and fucose disaccharides Fuc1-2Gal (#2), Fuc1-3GlcNAc (#85) and Fuc1-4GlcNAc (#66), which had average ranking from 64 to 96 % (Table S1 ). When looking at the larger fucosylated oligosaccharides that are present in human tissues, BambL has a clear preference for Type 2 oligosaccharides containing the Fuc1-2Gal1-4GlcNAc motif over the corresponding Type 1 oligosaccharides. Strong binding is observed towards H type 2 (blood group O) epitopes (#17 to #26, ranked 14 to 46%). Substitution by a second fucose on GlcNAc is tolerated since Lewis Y (Le Y ) epitopes (#121 to #123 ranked 29 to 45%) are also good ligands. On the other hand, H type 1 epitopes (#3 to #15) are only weakly recognized (ranked at 0 to 10%) and blood group A and B are bound only as trisaccharides. Lewis a (ranked at 16-19%), Lewis X (14-26%) and Lewis b (containing terminal Type 1 H ranked at 32%) epitopes are medium range binding ligands.
Likewise, Fuc1-6GlcNAc-containing N-glycans give only low signals. Such preference for short and linear glycans is unusual and points towards a deep binding site that can accommodate only some conformation for the fucose-terminated oligosaccharides. The related lectin RSL from R. solanacearum gave a very similar specificity profile when assayed on the glycan chips using the same conditions (Figur S1 in Suppl. Inf.).
Since glycans immobilized on microarrays may have different behaviour than in solution, SPR experiments were run using competition of soluble ligands with assays of BambL binding to a chip presenting multivalent fucose residues. Increasing concentrations of soluble ligands were used to determine IC50 as exemplified in Figure S2 (Suppl. Inf.). Data from inhibition assays using additional oligosaccharides are shown in Table 3 , where di-and trisaccharides, appear to be the most efficient for competing with the binding of BambL to a multivalent fucose surface, the best inhibitors being the A-tri and H-type5 (FucLac) trisaccharides. The Fuc1-6GlcNAc disaccharide, which was not assayed on the Glycan Array, appears to be as good a ligand as other Fuc-containing disaccharides. Longer ligands have weaker inhibitory potential, consistent with the binding on the glycan array. However, H-type 2 and Le Y perform much better than the other oligosaccharides, confirming the preference of the lectin for the Fuc1-2Gal1-4GlcNAc motif, as demonstrated on the glycan microarray.
Determination of affinity constants ─ The binding of BambL to human glycosidic epitopes was further characterized by titration microcalorimetry to determine the association constant and thermodynamics characteristics of the interaction. Typical thermograms, such as the one obtained for A-tri, H-type 2 and XFG (Figure 2 ), display strong exothermic peaks at the beginning of the titration and only residual heat at the end. Titration occurs for a molar ratio ligand/protein around 2, indicating two binding sites per protein. Integration of data can be performed generally using a one site binding model, although an independent two-sites model yields a better fit for the H-type 2 epitope (Figure 2) . The dissociation constants listed in Table 4 Crystal structure of BambL and complexes with human fucosylated epitopes ─ Cocrystallization of BambL with different oligosaccharides gave rise to high quality crystals in about 5 days. All the different complexed structures contain three molecules in the asymmetric unit but present different space group and unit cell ( Table 2) . Since BambL presents 75% sequence identity with RSL and also exists as a trimer in solution, RSL trimer (PDB 2BT9) was used as a search model in the molecular replacement procedure for the FucLac complex structure. The trimer coordinates of that complex were then used to solve the other complexes structures.
All 87 amino acids of BambL could be modelled in each chain of the different structures. The N-terminal methionine was found oxidised in some case. BambL presents a sixbladed -propeller fold generated upon trimerisation where each monomer (A, B and C) consists of two small four-stranded anti-parallel beta-sheets ( Figure 3A) . The BambL-FucLac complex and RSL-MeFuc structures show an rsmd of 0.58 Å for 260 aligned CA as calculated with SSM (33) . The BambL/FucLac complex presents very low occupancy of ligands in the binding sites with only one fucose visible between the two blades of chain C. This seems to be due to a very tight packing. The structure was therefore not analyzed further.
BambL/fucose interaction ─ For the other BambL complexes obtained with B-tetra, H-type 1 and H-type 2 oligosacharides, interaction with the ligand is visible in 2 sites per monomer, i.e. 6 sites per -propeller ( Figure 3A) . One fucose binding site is located between the two β-sheets of a monomer (intramonomeric, Figure 3B ), whereas the second is at the interface between two neighboring monomers (intermonomeric, Figure 3C ). Although the two binding site are very similar, some differences are observed for amino acids in contact with fucose (Trp74 in site AA versus Tyr 29 in site AB), or for amino acids in the vicinity (Tyr35/Thr80 and Ser13/His58). Six hydrogen bonds between the fucose and protein have been observed (Figure 3) , with Arg15, Glu26, Trp79 and main chain of Ala38 for intramonomeric sites and with Arg60, Glu71, Trp34 and main chain of Ala83 for intermonomeric sites. Hydrophobic contacts also play important roles in the binding of fucose and this is the main structural difference between intra-and intermonomeric sites. In both cases an aromatic residue stacks against the fucose hydrophobic face with a tryptophan (Trp74) for intramonomeric site and a tyrosine (Tyr29) for intermonomeric site. The features of BambL binding sites are very close to the previously described fucose binding site of RSL (18) (Figure 3S in Suppl. Info.).
BambL / B-tetra complex ─ Structure of BambL in complex with blood group B tetrasaccharide has been solved at 1.75Å (Figure 4) . The electronic density map shows the α-fucose in all six sites but other monosaccharides are only visible in the intramonomeric sites with optimal electron density for the whole tetrasaccharide in sites B and C. In addition to the fucose hydrogen bond network described above, one hydrogen bond is created between O6 of the α-galactose and main chain O of Thr36. Oxygen O2 of the Gal is not close to the protein surface, rationalizing the fact that both blood group B (Gal) and blood group A (GalNAc) bind with the same affinity.
When considering the narrow funnel-shape of the binding site. (Figure 4) , the tetrasaccharide appears to be in a rather constrained conformation. Indeed, when analyzing the torsion angles at each glycosidic linkage, ( Figure 5 and Table S3 in Suppl. Inf.) the Gal1-3Gal linkage is characterized by  and  angles close to (140°, 140°). From previously calculated energy maps of this linkage (34) , this conformation is about 4 kcal above the global minium at (80°, 90°) ( Figure 5 ). The steric hindrance around the central galactose explains this constrained conformation. The situation would be different with less branched trisaccharide explaining the much higher affinity of A-tri, compared to longer oligosaccharide with crowded galactose.
BambL/H-type 1 tetrasaccharide complex ─ The structure of BambL complexed with H-type 1 tetrasaccharide has been solved at 1.6 Å resolution. As described above, all binding sites are occupied, but only site C displays the whole tetrasaccharide. In addition to the main fucose binding network, two hydrogen bonds are created between N-acetyl oxygen and O4 of GlcNAc and side chains of Trp74 and Asp30, respectively (Figure 4) . Another one is observed between O4 of the reducing Gal and nitrogen sidechain of Trp8. Three water molecules are involved in bridging interactions between the oligosaccharide in the protein. As observed for the BambL/B-tetra complex, the Gal residue linked to the Fuc is not involved in direct interactions. Analysis of the conformations at the glycosidic linkages indicates that the Fuc1-2Gal linkage adopts a low energy conformation, but the Gal1-3GlcNAc linkage is distorted with  angles values ranging between -37 to -56° ( Figure 5 and Table S3 in Suppl. Inf.), with an energy cost of 3 to 5 kcal/mol.
BambL/H-type 2 tetrasaccharide complex -In
BambL/Htype2 tetrasaccharide complex (1.68 Å resolution), clear electonic density for trisaccharides is observed in five of the six binding sites, and only Fuc can be observed in site BC. Although fucose is always bound in the same way in the main binding sites, the interactions with oligosaccharides are different for the intermolecular site and the intramolecular ones (Figure 4 ). In the intramolecular sites (A, B and C), two water mediated hydrogen bonds are established between O6 and N of GlcNAc and Trp74 and Asp30 side chains, respectively. In the intermolecular sites (AB and CA), the GlcNAc residue is oriented in a different manner and a direct hydrogen bond is observed between the oxygen of the N-acetyl group and Trp51, and a second one between O4 and side chain of Arg60. These different orientations of the GlcNAc residue are due to very different conformations of the Gal1-4GlNac linkage (Table S3 in Suppl. Inf). In the intramonomeric sites, ,  torsion angles in the range -70°, -130° are observed, corresponding to the energy minimum ( Figure 5 ). Conversely, in the intermonomeric binding sites, conformations with ,  close to (-70°, 80°) are observed, corresponding to a 150° tilt in the  angle, when compared to the previous one. This particular conformation corresponds to a secondary minimum on the energy maps with energy about 3 kcal/mol greater than the minimum ( Figure 5 ). This energy difference is easily compensated by the two direct hydrogen bonds that are observed between the GlcNAc residue and the protein in these sites.
The observation of two types of sites is in agreement with the ITC data. Only for H-type 2 tetrasaccharide, a two site model was required to fit with the experimental data. The two sites are slightly different in amino acids composition around the GlcNAc residue Ser13 and Trp74 in intramolecular site correspond to His58 and Tyr29 in the intermolecular one. As described above, the two sites differ by the number of hydrogen bonds to GlcNAc and by the conformational constraints. Nevertheless, the structural information do not allow for the identification of the medium affinity binding site (K D = 14 M) and the high affinity binding site (K D = 0.56 M) determined by ITC.
Binding of BambL to giant unilamellar vesicles
─ As a next step, the binding of BambL to human glycosidic epitopes was tested in a membranous environment by using giant unilamellar vesicles (GUVs) that contain glycosphingolipids.
The GUVs (typical diameters of 10 -30 µm) composed of 1,2-dioleoylphosphatidyl choline (DOPC; 64 mol%; spiked with 1mol% BodipyFL-C5-HPC, green), cholesterol (30 mol%), and various glycosphingolipids (5 mol%) were observed by fluorescence microscopy on incubation with Cy3-labelled BambL at room temperature ( Figure S4 in Suppl Inf.).
The experiments on GUVs clearly indicated that fucose is an absolute requirement for the binding of BambL. BambL does not bind to liposomes that are only composed of the phospholipid DOPC (data not shown), neither to lactotetraosylceramide, the non-fucosylated precursor of ABO and Lewis blood group antigens nor to globotriaosylceramide (Gb3) that belongs to the globoseries.
BambL was binding to almost all of the type 1, Lewis and ABO blood group glycosphingolipids with a clear preference to H and Lewis a. The binding to Lewis b, blood group A and B antigens was significantly reduced, most likely due to the additional sugar in the binding cavity. For ALewis b, i.e. a Lewis b oligosaccharide with a terminal non-reducing GalNAc residue, the most complex glycosphingolipid in the used type 1 series, hardly any binding of BambL was detected, probably due to the additional two sugars. We were not able to see a superior binding of BambL to glycosphingolipids of the type 2 series represented by Lewis X and Lewis Y compared to their isoforms of the type 1 seriesLewis a and Lewis b. One reason might be differences in the fatty acid composition of the receptor glycosphingolipid that seems to be important for the binding of lectins (35) . All glycosphingolipids of the type 1 series were isolated from human meconium and the type 2 species were isolated from dog intestines (28) . The less prominent differences in binding avidity of BambL to type 1 and type 2 glycosphingolipid species might result from lectin-induced glycosphingolipid clustering in a highly dynamic membrane environment.
Binding to human saliva and tissues ─ In order to get a better insight into the specificity of BambL and to evaluate the impact of the combined ABO, FUT2 and FUT3 polymorphisms on its ability to recognize human histo-blood group diversity, its binding to saliva samples was determined through an enzymelinked lectin assay ( Figure 6A ) and The difference with the fucose-specific plant lectin UEA-I used as positive control is shown on Figure 6B and specificity of the BambL binding to either secretor or nonsecretor saliva samples was ascertained through its complete inhibition by either fucose or 2'fucosyllactose ( Figure 6C ). BambL was able to recognize all saliva samples, including nonsecretor saliva (FUT2-/-) and Lewis negative saliva (FUT3-/-). Nevertheless, despite individual variations within subgroups, a significantly weaker binding was observed on saliva from nonsecretor individuals compared to secretor individuals, consistent with the IC50 results determined by SPR and the afficnity measurements. Likewise, the presence of the A or B epitopes decreased saliva recognition since the lectin binding to O-secretors was stronger than to non O-secretor saliva. Among secretors, no effect of the Lewis phenotype was observed. However, a significantly weaker binding was observed on saliva of nonsecretor Lewis negative individuals. Thus a combination of the lack of both FUT2 (Secretor) and FUT3 (Lewis) enzyme activities together with the presence of the A or B epitopes reduces BambL binding to human saliva mucins. The specificity of BambL differs from that of UEA-I that hardly recognized nonsecretor saliva samples although, quite similar to BambL, it showed a significantly lower binding to saliva from non O individuals among secretors. Yet, at variance with BambL, no effect of the Lewis phenotype was visible among either secretors or nonsecretors.
To get insight into the localization of BambL binding epitopes in human tissues, an histochemistry analysis was performed. Binding was almost restricted to epithelial cells, although some weak staining could be observed on the vascular endothelium ( Figure 6D) . No clear impact of the ABO secretor or Lewis status of the tissue donor could be observed; however, no tissue sample from nonsecretor Lewis negative individual was available to assay. In the respiratory tract, in addition to a clear staining of the bronchi epithelial cells, the strongest staining was observed on the mucous producing glands lining the trachea and bronchi. In the gastroduodenal junction, labeling of the surface epithelia of both the pyloric and duodenal regions was seen in all individuals tested, albeit at a lower intensity in nonsecretors, along with a strong staining of the pyloric glands and the Brünner's glands of the duodenum.
DISCUSSION AND CONCLUSION
Fucose-binding proteins with -propeller fold belong to a recently described lectin family (18, 36) . This group is characterized by strong affinity for fucose and high valency with six binding sites in proper orientation for binding to glycoconjugates on membranes. BambL is the first lectin of this family to have been identified in a human pathogen genome and our present work highlight its preference for blood group H and Lewis Y oligosaccharides resulting in stronger binding to human with both O and secretor phenotypes. Binding to the Lewis a epitope was accounted for by the stronger binding to Lewis positive phenotype individuals in the absence of H or Lewis Y (nonsecretors).
The analyses to determine the specificity of BambL, as reported here, were quite extensive and involved the identification of candidate glycans using the CFG glycan microarray to subsequently select a panel of glycan structures for more detaild analysis using physical methods including SPR, ITC, and binding to glycolipids in giant unilammelar vesicles. Interestingly, the data for the relative binding of BambL to the glycans on the microarray were in very close agreement with the observations made using solution equilibrium method of ITC as well as the equilibrium method of SPR and unilamellar binding method with fucosylated glycosphingolipids. Thus, the screening of hundreds of glycans on a microarray provides a rapid, high throughput approach that approximates the more time consuming and labor intensive physical methods, and allows a quick screen to select glycans for more rigorous and quantitative physical methods of analysis.
Recent evidence strongly suggests that the relationship between histo-blood group phenotypes and susceptibility to infection is a result of co-evolution between mammals and pathogens (37) (38) (39) . Polymorphism in the fucosyltransferase genes is responsible for a large part of the variability of glycan structures present on human epithelia. The FUT2 ''secretor'' gene encodes the fucosyltransferase that synthesizes the H antigen and its loss of activity results in absence of ABH antigens in the lung, saliva, and gut, i.e. the ''nonsecretor'' phenotype. In parallel, the loss of function of the FUT3 "Lewis" gene results in the Lewis negative phenotype (40) .
At the present time, only a limited number of pathogen receptors have been demonstrated to be responsible for the binding to specific blood group oligosaccharides. Most of them are from enteropathogenic microbes such as Helicobacter pylori (41) , Vibrio cholera (42) or noroviruses (43) . As for lung pathogens involved in lifethreatening infections in cystic fibrosis patients, two lectins specific for galactose and fucose have been characterized (44, 45) . However, a recent clinical study performed on a group of CF patients did not find any association between ABO blood group, secretor and Lewis phenotype with severity of P. aeruginosa infections (46) . No such study has been performed on bacteria of the Burkholderia complex yet, but since glycoconjugates fucosylation is increased in lung tissue of CF patients (47), histo-blood group oligosaccharides are a promising target for Burkholderia lectins.
Opportunistic bacteria in the environment of CF patients are at the origin of lung infections. P. aeruginosa and Bcc bacteria are environmental bacteria able to colonize a large variety of niches. Burkholderia ambifaria is more particularly associated with the plant rhizosphere. Fucose appears to be a common epitope between plant and mammals. It is part of the hemicelluloses fraction of plant cell wall and is present on plant N-glycoproteins (48) . Our results demonstrate that BambL binds efficiently to both plant and human fucosylated oligosaccharides. If BambL is expressed and present on bacterial surface, that is still to be demonstrated, the lectin may therefore be involved in the easy niche adaptation observed for B. ambifaria.
The present work deciphered the molecular basis of the specificity of BambL towards fucosylated oligosaccharides and contributes to the current efforts to understand the glycostrategies of human opportunistic pathogens and to develop glyco-based compounds with antiadhesive properties against such pathogens. Figure 1 by guest on October 5, 2017 
